158 related articles for article (PubMed ID: 33710138)
1. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
[TBL] [Abstract][Full Text] [Related]
2. Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics.
Rearden J; Hanlon AL; Ulrich C; Brooks-Carthon M; Sommers M
Oncol Nurs Forum; 2016 Jan; 43(1):57-66. PubMed ID: 26679445
[TBL] [Abstract][Full Text] [Related]
3. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.
Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413
[TBL] [Abstract][Full Text] [Related]
5. Involving American Indians and medically underserved rural populations in cancer clinical trials.
Guadagnolo BA; Petereit DG; Helbig P; Koop D; Kussman P; Fox Dunn E; Patnaik A
Clin Trials; 2009 Dec; 6(6):610-7. PubMed ID: 19933720
[TBL] [Abstract][Full Text] [Related]
6. Use of a clinical trial screening tool to enhance patient accrual.
St Germain DC; McCaskill-Stevens W
Cancer; 2021 May; 127(10):1630-1637. PubMed ID: 33606910
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers.
Mobley EM; Swami U; Mott S; Ounda A; Milhem M; Monga V
Oncol Res Treat; 2020; 43(5):196-203. PubMed ID: 32222709
[TBL] [Abstract][Full Text] [Related]
8. Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.
Carlson RW; Tu SW; Lane NM; Lai TL; Kemper CA; Musen MA; Shortliffe EH
Online J Curr Clin Trials; 1995 Mar; Doc No 179():[3347 words; 32 paragraphs]. PubMed ID: 7719564
[TBL] [Abstract][Full Text] [Related]
9. Enrollment in clinical cancer trials: how are we doing and what are the obstacles to improving enrollment rates? A 2-year retrospective review of pediatric cancer trial enrollment in New Zealand.
Dodgshun AJ; De Silva MP; Bradbeer P; Cross S
J Pediatr Hematol Oncol; 2014 Nov; 36(8):630-4. PubMed ID: 24577541
[TBL] [Abstract][Full Text] [Related]
10. The correlation between the number of eligible patients in routine clinical practice and the low recruitment level in clinical trials: a retrospective study using electronic medical records.
Sumi E; Teramukai S; Yamamoto K; Satoh M; Yamanaka K; Yokode M
Trials; 2013 Dec; 14():426. PubMed ID: 24326039
[TBL] [Abstract][Full Text] [Related]
11. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
[TBL] [Abstract][Full Text] [Related]
14. Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.
Mantripragada KC; Olszewski AJ; Schumacher A; Perez K; Birnbaum A; Reagan JL; Mega A; Khurshid H; Bartley C; Lombardo A; Rossiter R; Papa A; Bakalarski P; Safran H
J Oncol Pract; 2016 Apr; 12(4):e396-404. PubMed ID: 26907448
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.
Langford AT; Resnicow K; Dimond EP; Denicoff AM; Germain DS; McCaskill-Stevens W; Enos RA; Carrigan A; Wilkinson K; Go RS
Cancer; 2014 Mar; 120(6):877-84. PubMed ID: 24327389
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Maryland cancer patient participation in national cancer institute-supported cancer treatment clinical trials.
Baquet CR; Ellison GL; Mishra SI
J Clin Oncol; 2008 Jul; 26(20):3380-6. PubMed ID: 18612153
[TBL] [Abstract][Full Text] [Related]
17. Barriers to Clinical Trial Enrollment in Patients With Pancreatic Adenocarcinoma Eligible for Early-Phase Clinical Trials.
Galvin R; Chung C; Achenbach E; Dziadkowiec O; Sen S
Oncology (Williston Park); 2020 Oct; 34(10):407-412. PubMed ID: 33058107
[TBL] [Abstract][Full Text] [Related]
18. Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
Patel MA; Shah JL; Brinley FJ; Abrahamse PH; Veenstra CM; Schott AF
Cancer Med; 2023 Jun; 12(11):12802-12812. PubMed ID: 37151163
[TBL] [Abstract][Full Text] [Related]
19. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
[TBL] [Abstract][Full Text] [Related]
20. Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.
St Germain D; Denicoff AM; Dimond EP; Carrigan A; Enos RA; Gonzalez MM; Wilkinson K; Mathiason MA; Duggan B; Einolf S; McCaskill-Stevens W; Bryant DM; Thompson MA; Grubbs SS; Go RS
J Oncol Pract; 2014 Mar; 10(2):e73-80. PubMed ID: 24424313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
